Bicomponent nano- and microfiber aerogels for effective management of junctional hemorrhage
Year: 2025
Type: article
Abstract: Managing junctional hemorrhage is challenging due to ineffective existing techniques, with the groin being the most common site, accounting for approximately 19.2% of potentially survivable field deaths. Here, we report a bicomponent nano- and microfiber aerogel (NMA) for injection into deep, narrow junctional wounds to effectively halt bleeding. The aerogel comprises intertwined poly(lactic acid) nanofibers and poly(ε-caprolactone) microfibers, with mechanical properties tunable through crosslinking. Optimized aerogels demonstrate improved resilience, toughness, and elasticity, enabling rapid re-expansion upon blood contact. They demonstrate superior blood absorption and clotting efficacy compared to commercial products (i.e., QuikClot® Combat Gauze and XStat®). Most importantly, in a lethal swine junctional wound model (Yorkshire swine, both male and female, n = 5), aerogel treatment achieved immediate hemostasis, a 100% survival rate, no rebleeding, hemodynamic stability, and stable coagulation, hematologic, and arterial blood gas testing.
Source: Nature Communications
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $6,990
Awards: Injectable, Shape-Recoverable, and Resorbable Nanofiber Foams for Junctional Hemorrhage Control, INJECTABLE, SHAPE-RECOVERABLE, AND RESORBABLE NANOFIBER FOAMS FOR JUNCTIONAL HEMORRHAGE CONTROL, G4600159835, Novel Janus-type Antimicrobial Dressings for the Treatment of Biofilms in Chronic Wounds, G8473464542
OpenAlex ID: W4408283311
